Legis Daily

Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020

USA116th CongressHR-2477| House 
| Updated: 12/9/2020
Raul Ruiz

Raul Ruiz

Democratic Representative

California

Cosponsors (18)
John Katko (Republican)Chris Pappas (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Derek Kilmer (Democratic)C. A. Dutch Ruppersberger (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jackie Walorski (Republican)Suzan K. DelBene (Democratic)Ann M. Kuster (Democratic)Gus M. Bilirakis (Republican)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Zoe Lofgren (Democratic)Scott R. Tipton (Republican)Bradley Scott Schneider (Democratic)Bryan Steil (Republican)

Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020 or the BENES Act of 2020 This bill modifies requirements relating to Medicare enrollment, coverage of immunosuppressive drugs for kidney transplant recipients, secondary payer reporting, and hospice survey requirements. Among other provisions, the bill generally requires Medicare coverage to begin on the first day of the month following enrollment for individuals who enroll in the latter months of their initial enrollment period; requires Social Security account statements for individuals attaining ages 63 to 65 to include information about Medicare eligibility, late enrollment penalties, and other information; indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage; requires the Centers for Medicare & Medicaid Services to share Medicare Advantage and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries; and establishes survey requirements for, and enforcement mechanisms against, certified hospice programs under Medicare.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 2, 2019
Introduced in House
May 2, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 3, 2019
Referred to the Subcommittee on Health.
Jan 8, 2020
Subcommittee Hearings Held.
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2020
Ordered to be Reported (Amended) by Voice Vote.
Jul 15, 2020
Committee Consideration and Mark-up Session Held.
Dec 8, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-621, Part I.
Dec 8, 2020
Mr. Larson (CT) moved to suspend the rules and pass the bill, as amended.
Dec 8, 2020
Considered under suspension of the rules. (consideration: CR H6993-7000)
Dec 8, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 2477.
Dec 8, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Dec 8, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6993-6997)
Dec 8, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2020
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 2, 2019
    Introduced in House


  • May 2, 2019
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 3, 2019
    Referred to the Subcommittee on Health.


  • January 8, 2020
    Subcommittee Hearings Held.


  • March 11, 2020
    Forwarded by Subcommittee to Full Committee (Amended) .


  • March 11, 2020
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2020
    Ordered to be Reported (Amended) by Voice Vote.


  • July 15, 2020
    Committee Consideration and Mark-up Session Held.


  • December 8, 2020
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-621, Part I.


  • December 8, 2020
    Mr. Larson (CT) moved to suspend the rules and pass the bill, as amended.


  • December 8, 2020
    Considered under suspension of the rules. (consideration: CR H6993-7000)


  • December 8, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2477.


  • December 8, 2020
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.


  • December 8, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6993-6997)


  • December 8, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2020
    Received in the Senate and Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 116-1375: PAID Act
  • S 116-1989: PAID Act
  • HR 116-5821: HOSPICE Act
  • S 116-3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
  • S 116-1280: BENES Act of 2019
Administrative remediesCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth care qualityHealth facilities and institutionsImmunology and vaccinationLong-term, rehabilitative, and terminal careMedicareOrgan and tissue donation and transplantationPrescription drugsSocial Security Administration

Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020

USA116th CongressHR-2477| House 
| Updated: 12/9/2020
Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020 or the BENES Act of 2020 This bill modifies requirements relating to Medicare enrollment, coverage of immunosuppressive drugs for kidney transplant recipients, secondary payer reporting, and hospice survey requirements. Among other provisions, the bill generally requires Medicare coverage to begin on the first day of the month following enrollment for individuals who enroll in the latter months of their initial enrollment period; requires Social Security account statements for individuals attaining ages 63 to 65 to include information about Medicare eligibility, late enrollment penalties, and other information; indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage; requires the Centers for Medicare & Medicaid Services to share Medicare Advantage and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries; and establishes survey requirements for, and enforcement mechanisms against, certified hospice programs under Medicare.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 2, 2019
Introduced in House
May 2, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 3, 2019
Referred to the Subcommittee on Health.
Jan 8, 2020
Subcommittee Hearings Held.
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2020
Ordered to be Reported (Amended) by Voice Vote.
Jul 15, 2020
Committee Consideration and Mark-up Session Held.
Dec 8, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-621, Part I.
Dec 8, 2020
Mr. Larson (CT) moved to suspend the rules and pass the bill, as amended.
Dec 8, 2020
Considered under suspension of the rules. (consideration: CR H6993-7000)
Dec 8, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 2477.
Dec 8, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Dec 8, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6993-6997)
Dec 8, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2020
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 2, 2019
    Introduced in House


  • May 2, 2019
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 3, 2019
    Referred to the Subcommittee on Health.


  • January 8, 2020
    Subcommittee Hearings Held.


  • March 11, 2020
    Forwarded by Subcommittee to Full Committee (Amended) .


  • March 11, 2020
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2020
    Ordered to be Reported (Amended) by Voice Vote.


  • July 15, 2020
    Committee Consideration and Mark-up Session Held.


  • December 8, 2020
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-621, Part I.


  • December 8, 2020
    Mr. Larson (CT) moved to suspend the rules and pass the bill, as amended.


  • December 8, 2020
    Considered under suspension of the rules. (consideration: CR H6993-7000)


  • December 8, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2477.


  • December 8, 2020
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.


  • December 8, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6993-6997)


  • December 8, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2020
    Received in the Senate and Read twice and referred to the Committee on Finance.
Raul Ruiz

Raul Ruiz

Democratic Representative

California

Cosponsors (18)
John Katko (Republican)Chris Pappas (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Derek Kilmer (Democratic)C. A. Dutch Ruppersberger (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jackie Walorski (Republican)Suzan K. DelBene (Democratic)Ann M. Kuster (Democratic)Gus M. Bilirakis (Republican)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Zoe Lofgren (Democratic)Scott R. Tipton (Republican)Bradley Scott Schneider (Democratic)Bryan Steil (Republican)

Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-1375: PAID Act
  • S 116-1989: PAID Act
  • HR 116-5821: HOSPICE Act
  • S 116-3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
  • S 116-1280: BENES Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth care qualityHealth facilities and institutionsImmunology and vaccinationLong-term, rehabilitative, and terminal careMedicareOrgan and tissue donation and transplantationPrescription drugsSocial Security Administration